Lpa receptor agonists and antagonists and methods of use
CA 2402038 C · Owner: Virag, Tamas · Inventors: Xu, Huiping; Tigyi, Gabor; Miller, Duane D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compounds according to formula (I) as disclosed herein as well as pharmaceutical compositions which include those compounds. Also disclosed are methods of using such compounds which have , activity, as agonists or as antagonists of LPA receptors; such methods including inhibiting LPA , activity on an LPA receptor modulating LPA receptor activity, treating cancer, enhancing cell proliferation, and treating a wound. (see formula I)
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 19, 2001 and granted March 15, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 19, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 19, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.